Sofinnova Partners SAS - Aug 15, 2022 Form 4 Insider Report for CinCor Pharma, Inc. (CINC)

Role
10%+ Owner
Signature
Sofinnova Partners SAS, By /s/ Monique Saulnier, Managing Partner
Stock symbol
CINC
Transactions as of
Aug 15, 2022
Transactions value $
$3,999,990
Form type
4
Date filed
8/17/2022, 04:19 PM
Previous filing
Jan 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CINC Common Stock Purchase $4M +133K +3.26% $30.00 4.22M Aug 15, 2022 By Sofinnova Capital IX F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sofinnova Partners SAS is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may be deemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.